Lower Urinary Tract Symptoms
UroLift offers minimally-invasive treatment of benign prostatic hyperplasia (BPH) without risk of sexual dysfunction.
Sitting to urinate is associated with an improved urodynamic profile in lower urinary tract symptoms (LUTS).
Many urologists not uniformly adhering to AUA guidelines for the management of benign prostatic hyperplasia/lower urinary tract symptoms.
Men with diabetic peripheral neuropathy have an increased occurrence of erectile dysfunction and lower-urinary-tract symptoms.
Only 10% of men aged 45-69 years who progress from no or mild to moderate or severe lower urinary tract symptoms are treated, study finds.
Compared with standing, sitting was associated with significantly lower post-void residual volume.
Ejaculatory function worsens, however, in men taking 5 alpha-reductase inhibitors.
Range of risk factors identified for incidence and remission of ED, dyadic and solitary sexual desire.
About 30 percent of men experience an AUA symptoms index improvement of 3 or more points.
Improvements observed in urinary symptoms and bone mineral density.
Men with a body mass index of 30 kg/m2 or higher had a 39.3% prevalence of low testosterone, study finds.
Significant declines in International Prostate Symptom Score observed, regardless of whether or not men lost weight or used a phosphodiesterase-5 inhibitor.
Desmopressin appears to reduce nocturia and other LUTS while also significantly increasing testosterone levels in late-onset hypogonadism.
Study results underscore the need for additional research to find other surrogate markers of urinary infection.
Lower urinary tract symptoms actually improved in many men, with minimal change in PSA level.
Lower urinary tract symptoms (LUTS) are commonly attributed to benign prostatic hyperplasia.
Saw palmetto remains the most common herbal treatment for men with LUTS.
Orange or grapefruit juice consumption may be protective in men, study finds.
Highest intake was associated with a 46% decreased progression risk compared with the lowest intake.
Many men even experience an improvement in lower urinary tract symptoms.
Tadalafil plus finasteride improved symptoms scores better than finasteride plus placebo.
Lower urinary tract symptoms alone should raise suspicion for the malignancy.
Following surgery, symptom severity declined significantly and remained stable over 10 years.
Alpha blockers are the mostly commonly prescribed drugs to treat LUTS secondary to BPH.
If patients are not bothered by symptoms, they do not necessarily require treatment, Australian researcher says.
Treatment of LUTS secondary to BPH has evolved from surgical therapy to medical monotherapy, and now combination therapy.
Small study is the first prospective investigation of this procedure in the U.S.
A new study has found that tadalafil co-administered with finasteride significantly improved scores in men with lower urinary tract symptoms.
The procedure may be particularly useful in treatment men with prostates larger than 100 cc.
Outcomes similar to HoLEP-treated patients who did not have prior surgery.
- Optimal PSA Threshold For Targeted Biopsy Identified
- Plant-Based Phosphorus Best for Kidney Disease (CKD) Patients
- Testosterone Replacement Therapy (TRT) Beneficial in Diabetes Mellitus Patients
- Stopping Renal Cell Carcinoma (mRCC) Drugs Induces Tumor Flare
- Red Meat Contributes to Cardiovascular Disease (CVD) Risk Due to Gut Bacteria
- Chronic Kidney Disease (CKD) Patients Benefit from Exercise Rehab
- What effect does advertising to attract patients have on perception of the medical profession?
- Prior Kidney Donor Favorable Waitlist Policy is Working
- Brown Fat Could Help Manage Diabetes
- New 5-Star Dialysis Facility Rating System To Debut
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)